Irregular Sleep, Drinking Caffeine After 3PM Could Raise Your Risk Of Heart Attack And Stroke
I’ve always struggled with inconsistent sleep, staying up late and waking up at different times each day. My love for coffee was also on an all-time high with trying all the season specials. But it is only recently, I learned how this irregular sleep pattern and caffeine could increase my risk of heart attack and stroke. Now, I’m prioritizing a consistent sleep schedule and cutting out caffeine after 3 PM to protect my heart.
A new, shocking study shows that irregular sleep patterns can greatly increase the risk of heart attack and stroke. But that's not all: the timing of your caffeine intake could also play a critical role in your cardiovascular health. If you are struggling with inconsistent sleep patterns and regularly sipping on caffeinated beverages late in the day, you may be unknowingly putting yourself at risk for serious heart-related issues.
For most people, sleep is something of a given and we often only consider ourselves as long as we get our required seven to nine hours. However, according to a recent study conducted by researchers at the Children's Hospital of Eastern Ontario, it may not be that long after all. The study, which included more than 72,000 participants, found that people with irregular sleep patterns—those who fall asleep and wake up at vastly different times each day—face a 26% higher risk of experiencing a heart attack or stroke. This increased risk persisted even for those who managed to get enough sleep. The study followed up participants for eight years to track heart events such as heart attacks, strokes, and heart failure. The conclusions were clear: irregular sleep, even if it's sufficient in duration, is a major cardiovascular risk factor.
The researchers found that those whose sleep patterns were highly irregular had a significantly greater chance of life-threatening heart issues. The more erratic your sleep schedule, the greater the risk, regardless of how many hours you sleep. In fact, people with irregular sleep schedules showed worse cardiovascular health outcomes, including higher rates of high blood pressure, elevated stress hormones, and poor blood sugar and cholesterol management.
Senior scientist Dr. Jean-Philippe Chaput said "sleep regularity may be more relevant than sufficient sleep duration in modulating MACE [major adverse cardiovascular event] risk." In the study, it shows that our bodies are comfortable with consistency, and a varied sleep schedule may interfere with other processes that keep us healthy, especially the heart.
Another daily habit that may be putting your heart at risk is caffeine consumption after 3 PM. According to Dr. Chaput, the experts emphasize the need for a healthy sleep schedule and avoiding caffeine late in the day. Caffeine can stay in your blood for up to eight hours, and its consumption later in the afternoon can disrupt your sleep cycle.
Consistent, good-quality sleep is necessary for maintaining healthy cardiovascular function, and the disruption of this by late-day caffeine intake exacerbates the risks posed by irregular sleep. When you drink coffee, tea, or other caffeinated beverages too late, the stimulant effect on your nervous system makes it harder to fall asleep at a regular time. This can lead to inconsistent sleep patterns, which, as we have seen, can be harmful to heart health.
Dr Chaput insists that humans need to adopt practices that contribute to regularized sleep habits. This can be attained by establishing a proper sleeping and waking schedule, eliminating afternoon intake of stimulants such as caffeine, and making your body clock coincide with the lifestyle one leads.
According to the experts, the disturbance due to irregular sleep patterns impacts more than one physiological process involved in the maintenance of the healthy heart. For example, poor sleep can be associated with increased inflammation of the body, weakened immunity, and altered regulation of blood sugar and cholesterol, all of which contribute to increased blood pressure and weakening endothelial function, both associated with an increased risk for cardiovascular diseases. Sleep also plays a very important role in regulating stress hormones. Poor or disturbed sleep results in increased levels of cortisol, the stress hormone, which increases blood pressure and can have negative impacts on cardiovascular health over time.
Scientists hypothesize that these disturbances trigger a series of negative effects that enhance the risk of developing chronic heart conditions, including hypertension, atherosclerosis, or even heart failure.
In order to protect your heart, experts recommend several proactive measures to improve your sleep patterns and lifestyle. First, maintain a regular sleep schedule whereby you go to bed and wake up at the same time every day, including weekends. Consistency will keep your body's internal clock in check.
Along with regulating your sleep, paying attention to your caffeine habits is just as important. To reduce your risk of heart disease and stroke, experts suggest avoiding caffeine after 3 PM. If you’re sensitive to caffeine, this rule becomes even more critical.
In addition, the introduction of stress-reducing activities like yoga or mindfulness can also be beneficial to lower cortisol levels, and therefore both sleep and heart health can improve. A diet rich in antioxidants, healthy fats, and low on processed sugars also helps maintain cholesterol levels and reduce inflammation.
Apart from the timing of caffeine and your sleep schedule, another very overlooked factor is the quality of your sleep environment. Scientists have long known that the environment in which you sleep has a huge impact on the quality of your rest. Poor quality of sleep, even if your sleep schedule is regular, can cause health risks that are very much the same as those that arise from irregular sleep patterns.
Here’s an additional tip: make sure your bedroom is conducive to restful sleep. This means keeping your room dark, quiet, and cool. A temperature of around 65°F (18°C) is ideal for most people. Consider investing in a comfortable mattress and pillows, and avoid screen time at least 30 minutes before bed to allow your brain to unwind.
Irregular sleep, in association with taking caffeine in late parts of the day, can risk heart attack and stroke, but a simple maintenance of a sleep schedule, the reduction of consumption of afternoon caffeine, and sleep environmental awareness can definitely safeguard one's heart along with total health.
Your sleep is more than just a time for rest; it's a vital component of your long-term health, and maintaining consistency in your sleep habits is one of the best things you can do for your heart.
Credit: The Howard Stern Show/ Youtube
American radio personality Robin Quivers has announced being free of cancer after a 14-year journey battling the deadly disease.
Quivers, 73 — who has co-hosted The Howard Stern Show for over 40 years — first announced in 2012 that she had been diagnosed with stage 3 endometrial cancer.
She immediately underwent surgery, numerous rounds of chemotherapy, and radiation to treat the disease. After four years of remission, it returned in 2016.
Now, nearly 10 years later, Quivers is once again “cancer-free.” The radio personality shared the good news during the radio show, The Independent reported.
“Robin kicked cancer’s ass. They said it couldn’t be done,” Stern, 72, declared, calling it “a miracle.”
He recalled the moment Quivers called him with the news, saying, “I couldn’t believe it. And really, I’ve said this to Robin privately, but I would like to say it on the air. Like this is really a miracle.
“I’m gonna say this because this is really true. I’ve watched the whole thing. She took charge of her health. She started to do all the right things. She never deviated, and she really took it seriously.”
Stern and Quivers, who began their radio careers as newscasters at WIOO in Carlisle, Pennsylvania, have been together since 1981.
Also read: Ozempic-Like Weight-Loss Drugs May Cut Breast Cancer Risk By A Third, Finds Research
Endometrial cancer begins in the endometrium, the inner lining of the uterus. Most uterine cancers are endometrial cancer. If untreated, it can spread to nearby organs such as the bladder, rectum, or more distant organs through the lymphatic system or bloodstream.
The endometrium is highly sensitive to hormonal changes, particularly the balance between estrogen and progesterone. When the body is exposed to excess estrogen without adequate progesterone, the endometrial lining grows excessively. Over time, this prolonged stimulation leads to abnormal cell changes and increases the risk of developing endometrial cancer or uterine cancer.
Dr Fahad Afzal, Consultant Oncologist at Saifee Hospital, told HealthandMe that obesity, PCOS, diabetes, and metabolic syndrome can contribute to hormonal imbalance and lead to endometrial cancer.
"Obesity is one of the most significant risk factors because excess body fat increases estrogen production. Women who are obese therefore have higher levels of estrogen, which stimulates the uterine lining,” the expert said.
Read More: Two NIH Researchers Charged For Smuggling Deactivated Mpox Virus Into US
According to World Health Organization data, its incidence is steadily rising, particularly in urban populations where lifestyle changes are more pronounced.”
Dr Smit Sheth, cancer physician at MOC Cancer Care & Research Centre, Mulund, said, “Hormones play a crucial role in a woman’s reproductive health, but when they fall out of balance, they can also increase the risk of certain cancers, including endometrial cancer".
The good news is that endometrial cancer typically grows slowly and is often detected early through regular gynecological exams.
Warning signs that should never be overlooked include
Simple lifestyle changes, maintaining a healthy weight, regular exercise, a balanced diet, managing chronic conditions like diabetes or hypertension, and timely medical check-ups can significantly reduce risk.
Credit: iStock
For years, moderate alcohol consumption, particularly a daily glass of wine, has been associated with potential health benefits, especially for heart health. However, in recent years, a growing body of research, including warnings from the World Health Organization (WHO) and other health agencies, has highlighted that alcohol poses significant health risks from the very first drink.
A recent expert review published in the Journal of Hepatology reiterated this concern, concluding that there is no universally safe level of alcohol consumption.
After examining recent evidence on alcohol use and health outcomes, researchers from the University of Wisconsin concluded that excessive alcohol consumption is unquestionably harmful and that defining a universally "safe" level of drinking remains unsupported by current scientific evidence.
According to the authors, the health risks associated with alcohol vary considerably from person to person. Factors such as age, sex, genetics, underlying medical conditions, medications, and pregnancy status can all influence how alcohol affects an individual's health.
Also read: 844 Million Adults Worldwide Living With Chronic Kidney Disease: Lancet Study
The researchers also questioned the long-standing belief that moderate drinking provides significant cardiovascular benefits.
They found that recent evidence does not support recommending regular alcohol consumption for health purposes. Instead, the review suggests that any potential benefits must be weighed against known risks, including cancer, liver disease, and other alcohol-related harms.
The review adds to a growing body of evidence linking alcohol consumption to an increased risk of several cancers.
A May 2026 study linked alcohol to 62 disorders, ranging from heart and digestive diseases to mental and neurological conditions and cancers.
The study, published in the journal Addiction, showed that the fully alcohol-attributable conditions are mainly grouped under non-communicable diseases and injuries.
These include:
The data also included psychotic disorders, gastritis, ulcers, pancreatitis, fatty liver disease, pregnancy- and perinatal-related conditions such as fetal alcohol syndrome and fetal alcohol spectrum disorders, as well as external causes and injuries, including alcohol poisoning.
"These conditions are 100 per cent alcohol attributable, meaning these diseases would not even exist in the world without alcohol use," said Jürgen Rehm, senior scientist at the Institute for Mental Health Policy Research in Toronto and part of the study team, according to CNN.
"There are another 30 diseases in which alcohol plays a role, such as breast and other cancers, heart disease, stroke, diabetes, and dementia," Rehm said. "These diseases would exist even without alcohol use, but alcohol use is responsible for a certain proportion of them."
The global burden of alcohol-related health issues is immense. The US National Institutes of Health (NIH) estimated that alcohol-related conditions could cost the United States nearly $1.87 trillion between 2011 and 2050, equivalent to about 1.45 per cent of the country's GDP. The NIH also criticized the lack of clear public messaging, which has allowed myths about alcohol's safety to persist for decades.
In 2023, the World Health Organization reinforced this warning. In a statement published in The Lancet Public Health, it declared that there is no safe level of alcohol consumption that does not affect health.
Credit: AI generated image
While GLP-1 drugs have shown their effectiveness in reducing weight and managing diabetes, new research suggests they may also help reduce the risk of cancer, particularly breast cancer.
According to a new study by researchers from the University of Pennsylvania, US, women between the ages of 45 and 80 who took a GLP-1 medication were 30 per cent less likely to develop breast cancer. The analysis was based on data from more than 110,000 women.
"While the study does not definitively confirm an association between GLP-1 medications and reduced breast cancer incidence, it does add to the growing body of evidence suggesting that it's worth investigating these weight-loss drugs as potential cancer prevention tools," the researchers said.
"GLP-1 medications are intriguing from a cancer research perspective because they weren't designed for cancer therapy, but they do affect many different targets and pathways associated with cancer development, so we're eager to study them in this context," said Elizabeth McDonald, Professor of Radiology at the University of Pennsylvania's Perelman School of Medicine.
The findings were presented at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago and were also published in JCO Oncology Practice.
Also read: I’m Cancer-Free After 14 Years, Says Robin Quivers
Breast cancer is the leading cause of cancer mortality among women worldwide and the most common cancer diagnosed overall, accounting for approximately 2.3 million new cases and 670,000 deaths annually, according to the World Health Organization. Every year, breast cancer accounts for about 30% of all new cancer cases in US women.
Beyond breast cancer screening through mammography or MRI, medical or surgical interventions to reduce breast cancer risk remain limited and can be life-altering.
Prophylactic mastectomy is recommended for some individuals with genetic mutations that significantly increase their lifetime risk of breast cancer. Tamoxifen is also highly effective in reducing breast cancer incidence among high-risk patients, but its uptake remains limited because of known side effects. In contrast, GLP-1 medications are already widely used by millions of Americans.
"Ultimately, we want to find better options to prevent breast cancer," McDonald said. "It's been encouraging to see the survival rates for breast cancer improve over recent decades, and we'd love to see the same gains in prevention."
Read More: Norovirus Spreading Across US: What To Know About The Highly Contagious Vomiting Virus
Another study by researchers at the Cleveland Clinic suggested that glucagon-like peptide-1 (GLP-1) medications may help slow the spread of several obesity-related cancers, including lung, breast, colorectal and liver cancers.
The researchers found that across six of the seven malignancies studied, GLP-1 receptor agonist exposure was associated with reduced metastatic progression, with significant reductions observed in non-small cell lung cancer, breast cancer, colorectal cancer and hepatocellular carcinoma.
The study included 12,112 patients with obesity-related cancers ranging from stage 1 to stage 3. Half of the participants began taking a GLP-1 medication after their cancer diagnosis, while the remaining participants were treated with DPP-4 inhibitors, commonly known as "gliptins", a different class of diabetes medications.
The comparison showed that patients who took GLP-1 medications had a substantially lower progression to stage 4 disease across four cancer types.
"Our study found that use of GLP-1 drugs, compared to DPP-4 inhibitors and other antidiabetic drugs, was associated with a meaningful reduction in cancer progression across four solid tumor types," said study author Mark David Orland from the Taussig Cancer Institute at Cleveland Clinic.
Read: Can Wegovy Improve Survival In Breast Cancer Patients? This Study Suggests It Could
Recognizing the signs and symptoms of breast cancer can help ensure a prompt diagnosis. Breast cancer can cause a wide array of symptoms, including:
© 2024 Bennett, Coleman & Company Limited